Literature DB >> 25933632

Diabetes Associated Markers After Bariatric Surgery: Fetuin-A, but Not Matrix Metalloproteinase-7, Is Reduced.

Po-Jen Yang1,2,3, Kong-Han Ser4, Ming-Tsan Lin5, Hsiao-Ching Nien6,7, Chiung-Nien Chen8, Wei-Shiung Yang9,10, Wei-Jei Lee11.   

Abstract

BACKGROUND: Recent studies showed that fetuin-A and matrix metalloproteinase-7 (MMP-7) are type 2 diabetes mellitus (T2DM)-associated markers. Bariatric surgery not only reduces body weight but also improves T2DM. This study aimed to investigate the changes of fetuin-A and MMP-7 in obese subjects with and without T2DM after bariatric surgery.
METHODS: We enrolled 130 obese subjects that received bariatric surgery, including 41 Roux-en-Y gastric bypass (RYGB), 67 mini-gastric bypass (MGB), and 22 sleeve gastrectomy (SG) patients. Forty-three patients suffered from T2DM prior to surgery. The fasting serum fetuin-A and MMP-7 levels were measured before and 1 year after surgery.
RESULTS: Only five of 43 patients remained diabetic after surgery. Preoperative T2DM patients had higher fetuin-A and MMP-7 levels than non-T2DM subjects. RYGB, MGB, and SG all decreased the fetuin-A levels 1 year after the operation. The MMP-7 levels were not changed after RYGB, MGB, or SG. In multivariate analyses, the preoperative fetuin-A was significantly related to the diastolic blood pressure (DBP) and glycosylated hemoglobin (HbA1c), while the postoperative fetuin-A was independently related to the waist-to-hip ratio and HbA1c. Moreover, the preoperative MMP-7 level was significantly related to age, DBP, aspartate transaminase, alanine transaminase, and gamma-glutamyl transferase (rGT), while the postoperative MMP-7 level was independently related to age and rGT.
CONCLUSIONS: The fetuin-A and MMP-7 levels are both higher in obese T2DM than non-T2DM subjects. The level of fetuin-A is reduced after RYGB, MGB, and SG, but the level of MMP-7 remains unchanged.

Entities:  

Keywords:  Bariatric surgery; Diabetes; Fetuin-A; MMP-7; Obesity

Mesh:

Substances:

Year:  2015        PMID: 25933632     DOI: 10.1007/s11695-015-1688-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  29 in total

1.  Global healthcare expenditure on diabetes for 2010 and 2030.

Authors:  Ping Zhang; Xinzhi Zhang; Jonathan Brown; Dorte Vistisen; Richard Sicree; Jonathan Shaw; Gregory Nichols
Journal:  Diabetes Res Clin Pract       Date:  2010-02-19       Impact factor: 5.602

2.  Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial.

Authors:  Wei-Jei Lee; Po-Jui Yu; Weu Wang; Tai-Chi Chen; Po-Li Wei; Ming-Te Huang
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

3.  Bariatric surgery: Asia-Pacific perspective.

Authors:  Wei-Jei Lee; Weu Wang
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

4.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

5.  Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies.

Authors:  Guangli Du; Ziyu Song; Qin Zhang
Journal:  Prev Med       Date:  2013-04-06       Impact factor: 4.018

6.  Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels.

Authors:  Claudia Ress; Alexander Tschoner; Christian Ciardi; Markus W Laimer; Julia W Engl; Wolfgang Sturm; Helmut Weiss; Herbert Tilg; Christoph F Ebenbichler; Josef R Patsch; Susanne Kaser
Journal:  Eur Cytokine Netw       Date:  2010-03       Impact factor: 2.737

7.  Increased plasma concentration of matrix metalloproteinase-7 in patients with coronary artery disease.

Authors:  Lennart Nilsson; Lena Jonasson; Johnny Nijm; Anders Hamsten; Per Eriksson
Journal:  Clin Chem       Date:  2006-06-08       Impact factor: 8.327

8.  Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss.

Authors:  Johanna Maria Brix; Harald Stingl; Florian Höllerl; Gerit Holger Schernthaner; Hans-Peter Kopp; Guntram Schernthaner
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

9.  Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

10.  Bariatric surgery: an IDF statement for obese Type 2 diabetes.

Authors:  J B Dixon; P Zimmet; K G Alberti; F Rubino
Journal:  Diabet Med       Date:  2011-06       Impact factor: 4.359

View more
  10 in total

1.  Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery.

Authors:  Anne Christin Meyer-Gerspach; Ralph Peterli; Michael Moor; Philipp Madörin; Andreas Schötzau; Diana Nabers; Stefan Borgwardt; Christoph Beglinger; Oliver Bieri; Bettina K Wölnerhanssen
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

Review 2.  Effects of Bariatric Surgeries on Fetuin-A, Selenoprotein P, Angiopoietin-Like Protein 6, and Fibroblast Growth Factor 21 Concentration.

Authors:  Jakub Poloczek; Wojciech Kazura; Ewa Kwaśnicka; Janusz Gumprecht; Jerzy Jochem; Dominika Stygar
Journal:  J Diabetes Res       Date:  2021-08-06       Impact factor: 4.011

3.  Role of MMP-1 (-519A/G, -1607 1G/2G), MMP-3 (Lys45Glu), MMP-7 (-181A/G), and MMP-12 (-82A/G) Variants and Plasma MMP Levels on Obesity-Related Phenotypes and Microvascular Reactivity in a Tunisian Population.

Authors:  Soumaya Boumiza; Sarra Bchir; Hela Ben Nasr; Ammar Abbassi; Marie-Paule Jacob; Xavier Norel; Zouhair Tabka; Karim Chahed
Journal:  Dis Markers       Date:  2017-11-26       Impact factor: 3.434

4.  Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?

Authors:  Hsien-Hao Huang; Chun Yeh; Jung-Chien Chen; Tzong-Hsi Lee; Shu-Chun Chen; Wei-Jei Lee; Chih-Yen Chen
Journal:  PeerJ       Date:  2018-06-12       Impact factor: 2.984

Review 5.  Behavior of Metalloproteinases in Adipose Tissue, Liver and Arterial Wall: An Update of Extracellular Matrix Remodeling.

Authors:  Gabriela Berg; Magalí Barchuk; Verónica Miksztowicz
Journal:  Cells       Date:  2019-02-14       Impact factor: 6.600

6.  Larger omental adipocytes correlate with greater Fetuin-A reduction following sleeve gastrectomy.

Authors:  Katie N Robinson; Blair Rowitz; Uretz J Oliphant; Sharon M Donovan; Margarita Teran-Garcia
Journal:  BMC Obes       Date:  2019-05-06

Review 7.  Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review.

Authors:  Lynda Bourebaba; Krzysztof Marycz
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

8.  Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes.

Authors:  Pedro Magalhães; Petra Zürbig; Harald Mischak; Erwin Schleicher
Journal:  Clin Kidney J       Date:  2020-10-23

9.  Serum Fibrinogen-Like Protein 1 Levels in Obese Patients Before and After Laparoscopic Sleeve Gastrectomy: A Six-Month Longitudinal Study.

Authors:  Diliqingna Dilimulati; Lei Du; Xiu Huang; Muthukumaran Jayachandran; Meili Cai; Yuqin Zhang; Donglei Zhou; Jiangfan Zhu; Lili Su; Manna Zhang; Shen Qu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-17       Impact factor: 3.249

10.  Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?

Authors:  Wen-Chi Wu; Wei-Jei Lee; Tzong-His Lee; Shu-Chun Chen; Chih-Yen Chen
Journal:  World J Diabetes       Date:  2020-06-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.